Concepedia

Golimumab in psoriatic arthritis: One‐year clinical efficacy, radiographic, and safety results from a phase III, randomized, placebo‐controlled trial

Arthur Kavanaugh, Désirée van der Heijde, Iain B. McInnes, Philip J. Mease, Gerald G. Krueger, Dafna D. Gladman, Juan J. Gómez‐Reino, Kim Papp, Anna Baratelle, Weichun Xu,

Arthritis & Rheumatism · 2012 · 206 citations · 22 references

DOIFull text

Open access

Abstract

Treatment of PsA with golimumab inhibited structural damage progression and demonstrated continued clinical efficacy and safety through 1 year.

References

22

The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection.

John E. Ware, Cathy D. Sherbourne · PubMed · 1992 · 34K citations

, , +22

The MOS 36-ltem Short-Form Health Survey (SF-36)

John E. Ware, Cathy D. Sherbourne · Medical Care · 1992 · 29.1K citations

, , +14

Modified disease activity scores that include twenty-eight-joint counts development and validation in a prospective longitudinal study of patients with rheumatoid arthritis

M.L.L. Prevoo, Martin A. van't Hof, H. H. Kuper et al. · Arthritis & Rheumatism · 1995 · 6.1K citations

Measurement of patient outcome in arthritis

James F. Fries, Patricia W. Spitz, R. Guy Kraines et al. · Arthritis & Rheumatism · 1980 · 4.3K citations

, , +13

American college of rheumatology preliminary definition of improvement in rheumatoid arthritis

David T. Felson, Jennifer J. Anderson, Maarten Boers et al. · Arthritis & Rheumatism · 1995 · 2.8K citations